Accelerating vaccine clinical development in Asia for pharmas, biotechs and their partners
Hideki Hasegawa, Director, Department of Pathology, at National Institute of Infectious Diseases (NIID), graduated from the Hokkaido University school of medicine in 1993 with M.D. and finished graduate school at Hokkaido University in 1997 with PhD. He studied at the R…more ›
Prof. Ken Ishii is currently a Project leader at the Laboratory of Adjuvant Innovation at the National Institute for Biomedical Innovation (NIBIO) as well as a Professor at the Laboratory of Vaccine Science at the Immunology Frontier Research Center (IFREC) of Osaka Uni…more ›
Dr. Shell Li has more than 21 years of life sciences / clinical development experience (16 yrs) in the pharmaceutical industry (Merck, Allergan, Amgen, Onyx, and currently Novartis) from basic research, product development, clinical development, to post marketing- Medic…more ›
Dr Alex Kudrin has graduated Orenburg Medical Academy in Russia in 1997 and received PhD / MD in Respiratory Medicine and Immunology from Moscow Medical University (2001) and MBA from Westminster University in London (2011). He was employed at Acambis, GlaxoSmithKline a…more ›
Bing Yan, MD, MBA is currently Head of Clinical Development Asia & China Vaccines Lead, Emerging Markets at Pfizer Inc. In his role, Dr. Yan is responsible for clinical research strategy and implementation in Asia across a broad range of therapeutic areas, with a pr…more ›
Join over 500 senior level executives at asia's only vaccines trials event
- 2-congress days, 30+ speakers
- 25+ sessions and 16hrs of defined content
- 10hrs+ of immersive networking events
Come to World Vaccine Trials Congress Asia 2012 and learn how to:
- Leverage on Asia’s clinical research capabilities to reduce R&D cost for vaccines
- Access a wider patient pool in Asia for trials for both adult and pediatric vaccines
- Navigate around regulatory complexities in conducting vaccine clinical trials in Asia
- Develop cost effective and efficient strategies in conducting vaccine clinical trial in Asia
- Identify and meet suitable CROs and other solution partners that have specialty in handling vaccines
- Identify the most suitable site locations to conduct vaccine trials in Asia
Sponsorship opportunities are now available
Come to World Vaccine Trials Congress Asia 2012 and learn how to:
- Reduce Drug manufacturing cost for vaccines
- Outsource vaccine manufacturing but maintaining quality
- Find the right partners either globally or in Asia that meets their needs and standards
- Ensure regulatory compliance for Asia markets and to address the global concerns on quality, reliability and authenticity
- Integrate the latest and advanced technological solutions
- Expand their business internationally to cover the international market
Who should sponsor:
- Contract Research Organizations
- Clinical Research Organizations
- Clinical Data Management Providers
- Patient Recruitment and Management Service Providers
- Drug Safety Assessment Solution Providers
- Bioanalytical service provider & Central Lab Services Providers
- Medical Writing Service Providers
- Regulatory Compliance Service Providers
- Cold Chain Logistics Service Providers
- Cold Chain Supply Chain Solution Providers
Who should attend:
- Pharmas
- Biotechs
- Hospitals
- Research Institutions
What to expect in 2012:
- 120+ senior vaccines executivesall with decision making capacities on their organisation, product or business unit
- 30+ C-level and VP speakersacross strategic manufacturing and cell culture disciplines
- 40+ research /academic poster sessions in a dedicated forum
- 4 conferences representing the complete vaccine value chain in one place
